UNSPSC 51283401: Penicillin o

This classification denotes a penicillin antibiotic with the molecular formula C13H18N2O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6246WH0S1O, chemically known as sodium (2s-(2alpha,5alpha,6beta))-6-((allylthio)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate but generally known as almecillin, which bears US NIH Compound Identifier 23569. European Medicines Agency schedules Almecillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05345MIG.

The term ALMECILLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). ALMECILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)CSCC=C.[NA].

UNSPSC 51283401 Penicillin O, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The four recent opportunities posted under this code involve naloxone and drug deactivation systems, therapeutic pharmacy initiatives, fire-rescue medical and first aid supplies, and generic multi-source pharmaceuticals and OTC products — none of which are penicillin or penicillin-specific procurement. The mismatch suggests either miscoding by issuing bodies or a legacy taxonomy issue; the code itself does not reflect the actual work being procured at the state and local level right now. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). The mix spans health systems, emergency response, and pharmacy benefit administration rather than a coherent product family.

Geographic activity centers on Florida, Texas, and Minnesota, with multistate reach through MMCAP. Recent solicitations include Seminole County's IFB for naloxone and safe drug deactivation systems (due July 26, 2023), the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (response deadline April 3, 2026), the City of Tampa's IFB for medical and first aid supplies for its Fire Department Rescue Division (due March 13, 2026, estimated contract value $700,000), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products across participating jurisdictions (due March 26, 2026). The Tampa procurement is designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount, while the MMCAP RFP requires compliance with cGMP, DSCSA, and FDA requirements with a 3 percent administrative fee on all purchases. No penicillin-specific procurement appears in the recent record; vendors evaluating this code should verify the correct UNSPSC assignment before committing resources.